Duluth, Georgia -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm and Phase One Medical, L.L.C., a medical device research and development company announced today that they have recently entered into an agreement for Hatch Medical to broker Phase One Medical’s patented medical device anchoring technology platforms, Fusion™ and Tissue Clip™.
The medical device anchoring platforms utilize shape memory alloy’s and proprietary design elements which can be integrated into implantable medical devices improving fixation and security of the implant. Phase One’s unique anchoring systems provide bi-directional migration resistance and are not dependant on radial force for fixation unlike hooks and barbs which are used in many implanted devices today. The company anticipates application of the technology to any implantable medical device relying on fixation to prevent migration such as AAA stent grafts, septal defect and PFO repair products and embolic devices.
Phase One Medical is initially utilizing both technology platforms in development of two highly differentiated removable vena cava filter systems for the prevention of Pulmonary Embolism (PE) resulting from Deep Vein Thrombosis (DVT). Both systems are safely and easily deployed using jugular and femoral access, are non-tilting and are easily removed when clinically warranted. Both filters will have the capability to treat large vena cava’s in excess of 35mm. For physicians who prefer wire guidance, the Tissue Clip™ system will utilize a unique over-the-wire delivery system featuring a .035” centering guidewire.
More than 600,000 people develop Deep Venous Thrombosis (DVT) annually with the most serious complication of DVT being Pulmonary Embolism (PE). PE is the third leading cause of acute cardiovascular death in the U. S. resulting in up to 200,000 deaths each year.
“We are very excited to be working with Phase One Medical once again. We believe the medical device anchoring technology platforms and the two vena cava filter systems clearly represent next generation performance in implantable device fixation and will provide unsurpassed patient safety with improved clinical options,” commented Paul Gianneschi, Managing Principal and Founder of Hatch Medical, L.L.C.
Adrian Ravenscroft, Phase One Medical’s Managing Partner added, “We are pleased to be working with Hatch Medical again as we did in the co-development and licensing of the EN Snare® device. Hatch Medical has a long history of successfully brokering new technology and medical devices. We look forward to working with Hatch in support of their efforts to license our unique medical device anchoring technology.”
Fusion™ and Tissue Clip™ anchoring technology as well as the vena cava filter systems are available for licensing or acquisition to interested third parties through an exclusive agreement with Hatch Medical.
Phase One Medical, L.L.C. is a privately held medical device research and development company. The company is focused on development of new and innovative technology supported by generation of strong IP positions. The company currently has several active device projects under development.
For additional information on this, or other Hatch Medical, L.L.C. products and services, e-mail the company at info@hatchmedical.com. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site at: http://www.hatchmedical.com.
Contact Paul Gianneschi, Managing Principal, 770-476-9940, or Steve Hvozda, Principal 404-892-0405.
Hatch Medical,
L.L.C.
Duluth, GA 30097
Phone: 770-476-9940
Facsimile: 770-476-7740
info@hatchmedical.com
© 2001 - 2008 Hatch Medical, L.L.C. - All rights reserved